Abu Dhabi-based FemTech startup Ovasave has raised $1.2 million in a pre-seed funding round to accelerate its mission of transforming women’s fertility and hormonal health across the MENA region.
The round was led by PlusVC, Annex Investments, and 25 Madison, New York, alongside UAE- and Saudi-based angel investors and family offices. The capital will enable Ovasave to scale operations across the GCC, deepen corporate partnerships, and launch a new version of its AI-powered mobile app.
The next phase of the app will offer features such as menstrual tracking, symptom monitoring, AI-driven treatment protocols, and seamless access to care, further pushing the region’s shift toward preventive and digital healthcare models.
“Abu Dhabi’s focus on innovation, healthcare, and entrepreneurship has created a competitive environment for founders and investors alike,” said Majd Abu Zant, Co-founder of Ovasave. “As an Abu Dhabi-based startup supported by Hub71, Ovasave has benefited from a strong regulatory framework, access to capital, and proximity to regional decision-makers. It’s the right environment to build and scale high-impact ventures, and from here, we are expanding into Saudi Arabia and the wider MENA region.”
Registered with the Department of Health – Abu Dhabi, Ovasave is backed by Hub71, the capital’s global tech ecosystem, aligning the venture with the UAE’s broader digital health and FemTech ambitions. The company plans to launch operations in Saudi Arabia this summer, with long-term expansion across MENA part of its three-year roadmap.
“There is a critical need for timely intervention in women’s health, particularly around fertility and hormonal health,” said Torkia Mahloul, Co-founder and CEO of Ovasave. “This funding marks a crucial step in our mission to disrupt women’s health and expand access to fertility and hormonal care across the region.”
Ovasave’s model addresses a long-standing gap in women’s healthcare by offering proactive, accessible, and cost-effective solutions. The startup’s approach is gaining traction amid rising investor interest in femtech innovation, as regional governments place a stronger focus on digital transformation and women’s empowerment.
According to a report by FemTech Analytics, the MENA FemTech market is expected to reach $3.8 billion by 2031, growing at a CAGR of 15% from 2021 to 2031.
As the region’s first wave of FemTech innovators gains momentum, Ovasave’s $1.2M raise signals growing investor confidence in women’s health innovation as both a high-impact and high-growth sector in the GCC and beyond.
–Input WAM
